COCH
Envoy Medical, Inc.
NASDAQ · Healthcare · Medical - Devices · US
$0.71
−2.75%0
Insider buys (3m)
0
Insider sells (3m)
$0.00
Net value (3m)
+10.0%
Price return (3m)
Form 4 filings
| Date | Insider | Activity | Shares | Price |
|---|---|---|---|---|
| Aug 26, 2026 | Potashnick Robert · officer: CAO & VP of Finance | A-Award | 250,000 | $0.75 |
| Jun 23, 2026 | Lucas Brent T. · director, officer: Chief Executive Officer | A-Award | 1,000,000 | $0.63 |
| Jun 4, 2026 | Lucas Brent T. · director, officer: Chief Executive Officer | A-Award | 32,856 | $0.60 |
| Apr 17, 2026 | McKhann Chas · director | A-Award | 100,000 | $0.72 |
| Feb 17, 2026 | Kantor Susan · director | Purchase | 96,150 | $0.40 |
| Feb 17, 2026 | Kantor Susan · director | Purchase | 57,690 | $0.40 |
| Feb 17, 2026 | BRYNELSEN CHARLES · director | Purchase | 1,000,000 | $0.40 |
| Feb 17, 2026 | BRYNELSEN CHARLES · director | Purchase | 600,000 | $0.40 |
| Feb 17, 2026 | Lucas Brent T. · director, officer: Chief Executive Officer | Purchase | 62,500 | $0.40 |
| Feb 17, 2026 | Lucas Brent T. · director, officer: Chief Executive Officer | Purchase | 37,500 | $0.40 |
| Feb 17, 2026 | TAYLOR GLEN A · 10 percent owner | Purchase | 18,750,000 | $0.40 |
| Feb 17, 2026 | TAYLOR GLEN A · 10 percent owner | Purchase | 11,250,000 | $0.40 |
| Feb 17, 2026 | Patel Mona Chetan · director | Purchase | 312,500 | $0.40 |
| Feb 17, 2026 | Patel Mona Chetan · director | Purchase | 187,500 | $0.40 |
| Feb 17, 2026 | Potashnick Robert · officer: Interim CFO | Purchase | 212,500 | $0.40 |
| Feb 17, 2026 | Potashnick Robert · officer: Interim CFO | Purchase | 127,500 | $0.40 |
| Feb 9, 2026 | Lucas Brent T. · director, officer: Chief Executive Officer | A-Award | 200,000 | $0.53 |
| Feb 9, 2026 | Potashnick Robert · officer: Interim CFO | A-Award | 15,000 | $0.53 |
| Dec 10, 2025 | Lucas Brent T. · director, officer: Chief Executive Officer | A-Award | 18,105 | $0.71 |
| Dec 5, 2025 | BRYNELSEN CHARLES · director | A-Award | 62,500 | $0.81 |
| Dec 5, 2025 | Crowe Michael Curtis · director | A-Award | 25,000 | $0.81 |
| Dec 5, 2025 | Patel Mona Chetan · director | A-Award | 25,000 | $0.81 |
| Dec 5, 2025 | Kantor Susan · director | A-Award | 62,500 | $0.81 |
| Dec 5, 2025 | Smith-Gomez Janis · director | A-Award | 25,000 | $0.81 |
| Sep 8, 2025 | TAYLOR GLEN A · director, 10 percent owner: | A-Award | 250,000 | $3.04 |
| Sep 8, 2025 | TAYLOR GLEN A · director, 10 percent owner: | A-Award | 750,000 | $1.48 |
| Sep 8, 2025 | TAYLOR GLEN A · director, 10 percent owner: | A-Award | 500,000 | $2.20 |
| Jul 8, 2025 | TAYLOR GLEN A · director, 10 percent owner: | A-Award | 750,000 | $1.48 |
| Jun 13, 2025 | Patel Mona Chetan · director | Purchase | 2,500 | $1.47 |
| Jun 10, 2025 | Patel Mona Chetan · director | Purchase | 10,000 | $1.46 |
Institutional positioning
13F filings over the trailing two quarters
New 22Increased 11Reduced 6Sold out 8
| Filer | Action | Shares | Filed |
|---|---|---|---|
| Nantahala Capital Management, LLC | Unchanged | 7,650,000 | Aug 19, 2026 |
| NANTAHALA CAPITAL MANAGEMENT, LLC | New Position | 7,650,000 | May 15, 2026 |
| BLEICHROEDER LP | New Position | 6,250,000 | May 14, 2026 |
| Bleichroeder LP | Unchanged | 6,250,000 | Aug 13, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | New Position | 881,672 | May 15, 2026 |
| VANGUARD CAPITAL MANAGEMENT LLC | Reduced | 880,214 | Aug 13, 2026 |
| DSG Capital Advisors, LLC | Unchanged | 625,000 | Aug 6, 2026 |
| DSG CAPITAL ADVISORS, LLC | New Position | 625,000 | Apr 27, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | Increased | 541,729 | Aug 12, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | Increased | 521,824 | May 15, 2026 |
| Focus Partners Wealth | Increased | 425,310 | Aug 12, 2026 |
| VANGUARD FIDUCIARY TRUST CO | Increased | 296,679 | Aug 13, 2026 |
| VANGUARD FIDUCIARY TRUST CO | New Position | 294,721 | May 8, 2026 |
| COLONY GROUP, LLC | Unchanged | 212,655 | May 15, 2026 |
| UBS Group AG | Increased | 190,838 | Aug 13, 2026 |
Insider activity from SEC Form 4; institutional positioning from 13F filings · Latest filing Aug 26, 2026